Atlas Trials

Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures

Clinical trial NCT02908516 · TERMINATED

Trial details

NCT number
NCT02908516
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hip FracturesBlood Loss
Start date
2017-09-18
Primary completion
2017-11-14
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.